Top

BMC Nephrology

Published in:

Open Access 01-12-2016 | Case report

Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?

Authors: Sassan Ghazan-Shahi, Joanne M. Bargman

Published in: BMC Nephrology | Issue 1/2016

Abstract

Background

Encapsulating peritoneal sclerosis (EPS) is classically described as progressive sclerosis and cocooning of the entire peritoneum; however, there has been limited number of reported cases of localized fibrosis as a variant form.

Case presentation

We describe two cases of acute bowel obstruction with isolated transition points in the setting of long-term peritoneal dialysis.

Conclusion

We postulate that some of the cases of small bowel obstruction with an obvious transition point in long-term peritoneal dialysis patients may represent a unique and localized form of EPS. We aim to emphasize the presence of macroscopic variations in presentation of EPS.

Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20 Suppl 4:S43–55.PubMed

Brown MC, Simpson K, Kerssens JJ, Mactier RA. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol. 2009;4:1222–9.CrossRefPubMedPubMedCentral

Kawanishi H. Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study. Perit Dial Int. 2001;21 Suppl 3:S67–71.PubMed

Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998;13:154–9.CrossRefPubMed

Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44:729–37.CrossRefPubMed

Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24:3209–15.CrossRefPubMed

Nakamoto H. Encapsulating peritoneal sclerosis—a clinician’s approach to diagnosis and medical treatment. Perit Dial Int. 2005;25 Suppl 4:S30–8.PubMed

Sampimon DE, Coester AM, Struijk DG, Krediet RT. Time course of peritoneal transport parameters in peritoneal dialysis patients who develop peritoneal sclerosis. Adv Perit Dial. 2007;23:107–11.PubMed

Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int. 2010;78:611–8.CrossRefPubMed

10.

Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int. 2005;25 Suppl 4:S19–29.PubMed

11.

Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract. 2009;111(2):c149–54. discussion c54.CrossRefPubMed

12.

Korte MR, Sampimon DE, Betjes MG, Krediet RT. Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol. 2011;7:528–38.PubMed

13.

Trigka K, Dousdampanis P, Chu M, Khan S, Ahmad M, Bargman JM, et al. Encapsulating peritoneal sclerosis: a single-center experience and review of theliterature. Int Urol Nephrol. 2011;43(2):519–26.CrossRefPubMed

14.

Kirkman MA, Heap S, Mitu–Pretorian OM, McGrath S, Pararajasingam R, Tavakoli A, et al. Posttransplant encapsulating peritoneal sclerosis localized to the terminal ileum. Perit Dial Int. 2010;30:480–2.CrossRefPubMed

15.

Habib SM, Hagen SM, Korte MR, Zietse R, Dor FJ, Betjes MG. Localized encapsulating peritoneal sclerosis constricting the terminal ileum--an unusual appearance requiring surgical intervention. Perit Dial Int. 2013;33(5):503–6.CrossRefPubMedPubMedCentral

Title: Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?
Authors: Sassan Ghazan-Shahi
Joanne M. Bargman
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI: https://doi.org/10.1186/s12882-015-0214-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Case report: acute bowel obstruction with an isolated transition point in peritoneal dialysis patients; a presentation of encapsulating peritoneal sclerosis?

Abstract

Background

Case presentation

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2016

Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke

Association between lower serum bicarbonate and renal hyperfiltration in the general population with preserved renal function: a cross-sectional study

Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data

Excessive diagnostic testing in acute kidney injury

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years – The PreKit-QoL study protocol

A case report of malignant hypertension in a young woman

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page